ARNA's gotten a reputation as being pretty respectful of its channel boundaries and it has two well defined pivot points on high and low to watch.
Without a news event to trigger a major move, it could continue to bounce back and forth in here.
Remember though that long term this company is heavily investing in 1 specific drug/area and is pushed by the performance of other companies like VVUS as well as regulatory barriers.